RhumbLine Advisers’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-130,067
| Closed | -$150K | – | 3330 |
|
|
2022
Q1 | $150K | Buy |
130,067
+17,351
| +15% | +$28.3K | ﹤0.01% | 2818 |
|
|
2021
Q4 | $282K | Sell |
112,716
-1,123
| -1% | -$4.41K | ﹤0.01% | 2723 |
|
|
2021
Q3 | $583K | Sell |
113,839
-18,691
| -14% | -$114K | ﹤0.01% | 2477 |
|
|
2021
Q2 | $1.1M | Sell |
132,530
-18,576
| -12% | -$157K | ﹤0.01% | 2200 |
|
|
2021
Q1 | $1.32M | Sell |
151,106
-1,375
| -0.9% | -$14.2K | ﹤0.01% | 2082 |
|
|
2020
Q4 | $1.66M | Buy |
152,481
+1,426
| +0.9% | +$17.6K | ﹤0.01% | 1934 |
|
|
2020
Q3 | $1.8M | Sell |
151,055
-18,528
| -11% | -$248K | ﹤0.01% | 1735 |
|
|
2020
Q2 | $2.72M | Buy |
169,583
+33,558
| +25% | +$586K | ﹤0.01% | 1557 |
|
|
2020
Q1 | $2.11M | Buy |
136,025
+9,977
| +8% | +$214K | ﹤0.01% | 1516 |
|
|
2019
Q4 | $3.1M | Buy |
126,048
+3,646
| +3% | +$54.1K | 0.01% | 1543 |
|
|
2019
Q3 | $1.26M | Sell |
122,402
-874
| -0.7% | -$11K | ﹤0.01% | 1932 |
|
|
2019
Q2 | $1.55M | Buy |
123,276
+19,810
| +19% | +$255K | ﹤0.01% | 1876 |
|
|
2019
Q1 | $1.28M | Buy |
103,466
+14,072
| +16% | +$157K | ﹤0.01% | 1918 |
|
|
2018
Q4 | $551K | Buy |
89,394
+38,852
| +77% | +$297K | ﹤0.01% | 2252 |
|
|
2018
Q3 | $536K | Sell |
50,542
-2,108
| -4% | -$24.1K | ﹤0.01% | 2246 |
|
|
2018
Q2 | $713K | Buy |
52,650
+4,440
| +9% | +$69.1K | ﹤0.01% | 2156 |
|
|
2018
Q1 | $856K | Buy |
48,210
+4,130
| +9% | +$69.8K | ﹤0.01% | 2011 |
|
|
2017
Q4 | $553K | Sell |
44,080
-6,540
| -13% | -$95.1K | ﹤0.01% | 2194 |
|
|
2017
Q3 | $964K | Buy |
50,620
+480
| +1% | +$7.32K | ﹤0.01% | 1997 |
|
|
2017
Q2 | $757K | Buy |
50,140
+1,257
| +3% | +$19K | ﹤0.01% | 2096 |
|
|
2017
Q1 | $838K | Buy |
48,883
+1,448
| +3% | +$19.3K | ﹤0.01% | 2010 |
|
|
2016
Q4 | $574K | Buy |
47,435
+5,096
| +12% | +$53.2K | ﹤0.01% | 2151 |
|
|
2016
Q3 | $417K | Buy |
42,339
+920
| +2% | +$8.4K | ﹤0.01% | 2305 |
|
|
2016
Q2 | $424K | Buy |
41,419
+5,740
| +16% | +$64K | ﹤0.01% | 2307 |
|
|
2016
Q1 | $432K | Buy |
35,679
+8,045
| +29% | +$81.4K | ﹤0.01% | 2321 |
|
|
2015
Q4 | $443K | Buy |
27,634
+1,855
| +7% | +$27.5K | ﹤0.01% | 2314 |
|
|
2015
Q3 | $332K | Buy |
25,779
+1,019
| +4% | +$20.6K | ﹤0.01% | 2476 |
|
|
2015
Q2 | $594K | Buy |
24,760
+12,245
| +98% | +$236K | ﹤0.01% | 2218 |
|
|
2015
Q1 | $235K | Buy |
12,515
+1,800
| +17% | +$37.2K | ﹤0.01% | 2753 |
|
|
2014
Q4 | $202K | Sell |
10,715
-200
| -2% | -$4.67K | ﹤0.01% | 2810 |
|
|
2014
Q3 | $296K | Buy |
10,915
+400
| +4% | +$12.4K | ﹤0.01% | 2527 |
|
|
2014
Q2 | $327K | Buy |
+10,515
| New | +$248K | ﹤0.01% | 2547 |
|
|
2013
Q4 | – | Sell |
-5,225
| Closed | -$210K | – | 3025 |
|
|
2013
Q3 | $210K | Buy |
+5,225
| New | +$177K | ﹤0.01% | 2758 |
|
Other funds holding EPZM
RM
NM
RSCM
PAI
PIM
RCMNY
WP
